Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06106269
- Status
- Recruiting
Conditions
- Internal Hemorrhoid
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- Rectal Artery Embolization — DEVICESubjects will undergo planned rectal artery embolization (RAE) in Vascular and Interventional Radiology per standard clinical protocol.
Study Details
This study will assess how effective and safe rectal artery embolization works to treat symptomatic bleeding predominant internal hemorrhoids.
Key Dates
- Start date
- Jun 7, 2024
- Status verified
- Jun 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
Primary Outcome Measure
Change in French bleeding score (FBS) [ Time Frame: Baseline, 1, 3, 6 and 12 months ]
Central Contacts
- Desirae Howe-Clayton507-255-0111
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic Minnesota | Rochester | Minnesota | 55905 | - |
Find similar trials in Rochester, MN
By research site
Related Studies
- Prospective HemorrhoIdaL EmboliSation (PILES) RegistryRecruiting · Joint & Vascular Institute · Libertyville, Illinois